Hydrochlorothiazide

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

57 Suppliers, 31 USDMF, 22 CEP/COS, 8 JDMF, 10 EU WC, 17 KDMF, 17 NDC API, 24 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

3063 Dossiers, 874 FDA Orange Book, 1374 Europe, 235 Canada, 34 Australia, 161 South Africa, 385 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 25MG;25MG, TABLET;ORAL - 50MG;50MG, CAPSULE;ORAL - 25MG;37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG;37.5MG, TABLET;ORAL - 50MG;75MG, TABLET;ORAL - 10MG;25MG, TABLET;ORAL - 5MG;12.5MG, TABLET;ORAL - 12.5MG;10MG, TABLET;ORAL - 12.5MG;20MG, TABLET;ORAL - 25MG;20MG, TABLET;ORAL - 12.5MG;100MG, TABLET;ORAL - 12.5MG;50MG, TABLET;ORAL - 25MG;100MG, CAPSULE;ORAL - 12.5MG, TABLET;ORAL - 12.5MG;150MG, TABLET;ORAL - 12.5MG;300MG, TABLET;ORAL - 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 12.5MG;160MG, TABLET;ORAL - 12.5MG;320MG, TABLET;ORAL - 12.5MG;80MG, TABLET;ORAL - 25MG;160MG, TABLET;ORAL - 25MG;320MG, TABLET;ORAL - 16MG;12.5MG, TABLET;ORAL - 32MG;12.5MG, TABLET;ORAL - 32MG;25MG, TABLET;ORAL - 12.5MG;40MG, TABLET;ORAL - 12.5MG;80MG, TABLET;ORAL - 25MG;80MG, TABLET;ORAL - 12.5MG;20MG, TABLET;ORAL - 12.5MG;40MG, TABLET;ORAL - 25MG;40MG, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG, TABLET;ORAL - EQ 10MG BASE;25MG;160MG, TABLET;ORAL - EQ 10MG BASE;25MG;320MG, TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG, TABLET;ORAL - EQ 5MG BASE;25MG;160MG, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

Suppliers, 39 Kerry, 39 BASF, 29 Roquette, 25 SPI Pharma, 20 Microlex e.U, 16 Seppic, 14 Nanjing Well Pharmaceutical, 13 Corel Pharma Chem, 13 Gangwal Healthcare, 13 Gangwal Chemicals, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 Sigachi Industries, 10 Actylis, 9 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Boai NKY Pharmaceuticals Ltd, 7 Ideal Cures Pvt Ltd, 7 DFE Pharma, 6 Prachin Chemical, 6 Vasa Pharmachem, 6 Lonza Capsugel, 5 Ingredion Pharma Solutions, 5 Pharmatrans-Sanaq, 4 ACG Worldwide, 4 Alcedo Pharmachem, 4 DKSH, 4 Kima Chemical, 3 Jai Radhe Sales, 3 Rochem International Inc, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 3 Finar, 3 Clariant, 2 Pfanstiehl, 2 Nanjing Bold Chemical, 2 Qualicaps, 2 Nomisma Healthcare, 2 Seqens, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Evonik, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Doshion Polyscience, 1 NEWEDGE Overseas, 1 Chynops Pharma, 1 Pharm-RX Chemical, 1 Avesta Pharma, 1 Zhejiang Huakang Pharmaceutical, 1 Minakem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Aeon Procare, 1 Huzhou Sunflower Pharmaceutical, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

105 Fillers, Diluents & Binders, 60 Coating Systems & Additives, 55 Direct Compression, 50 Disintegrants & Superdisintegrants, 39 Granulation, 38 Controlled & Modified Release, 37 Solubilizers, 37 Lubricants & Glidants, 32 Film Formers & Plasticizers, 31 Thickeners and Stabilizers, 29 Topical, 29 Taste Masking, 28 Parenteral, 21 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 10 Emulsifying Agents, 10 API Stability Enhancers, 9 Empty Capsules, 6 Surfactant & Foaming Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

94 US Medicaid Prescriptions, 1308 Finished Drug Prices

MARKET PLACE

29 APIs, 18 DOSSIERS // FDF

PATENTS

4 US Patents

4 US Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 3 EDQM Standards, 1 USP Standards, 3 JP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

3 Data Compilation & Company Tracker #PharmaFlow, 143 News

Find Clinical Drug Pipeline Developments & Deals for Hydrochlorothiazide